|
|
CALL FOR ABSTRACTS
The 2012 NLA Annual Scientific Sessions Committee invites the submission of abstracts to be presented at the 2012 NLA Annual Scientific Sessions that will be held in Scottsdale, AZ from May 31 - June 3, 2012. Submitted abstracts will be considered for poster presentation and oral presentation at the meeting. All accepted abstracts will be published in the May/June 2012 edition of the Journal of Clinical Lipidology and will be posted on the 2012 NLA Annual Meeting website.
All abstracts must be submitted online via the NLA abstract submission website using the online submission form. Please be sure to read all instructions, information and policies closely.
Important Dates
Abstract Submission Deadline
Monday, April 2, 2012
5:00pm PDT
Abstract Acceptance Notification
Monday, April 16, 2012
Presenting Author Registration Deadline
Friday, May 11, 2012
Presentation Methods
NEW THIS YEAR! In addition to posters being displayed at the meeting during the designated hours, selected abstract submissions will be identified for a live oral presentation session. An NLA research award will be provided for the best submission.
The NLA Abstract Review Committee will select 8 abstracts to be presented during a designated session on the meeting program. Authors will have 12 minutes to present their research, with 3 minutes to follow for questions and answers.
When completing the online abstract submission form, you will be asked to indicate your interest in having your research considered for the oral presentation session.
Travel Grants and Awards
NLA Young Investigator Awards
Sponsored by LipoScience
Lead presenters with accepted abstracts who are Young Investigators (in training students, residents and fellows or members in practice for < 5 years) will have the chance to compete for the NLA's enhanced Young Investigator Award offering a $1,000 cash prize and certificate to first place and a $500 cash prize to second and third place. The Award winners will receive recognition at a special ceremony on Saturday, June 2, 2012. In addition, the first place winner will be selected to present their abstract during the live Oral Presentation session and have their poster printed in the Lipid Spin following the meeting.
All Young Investigator selected lead authors will receive complimentary registration to the Scientific Sessions and will be eligible to receive a travel grant to get to and from the meeting.
Abstract Submission Instructions
Please read through the submission instructions below before preparing your abstract:
- Read the General Information and Policies for the submission of an abstract.
- Write your abstract, following the Abstract Guidelines.
- Select a Topic that best relates to your abstract.
- Review the Acceptance and Presentation Process for abstracts.
- Submit your abstract through the Online Abstract Submission Form.
- Register to attend the 2012 NLA Annual Scientific Sessions by Friday, May 11, 2012. (NLA staff will contact you with a meeting registration form to register for the meeting if your abstract has been approved).
General Information and Policies
- You may complete your abstract submission over multiple sessions. As you will see, there will be a point in the process when you MUST finalize your abstract and make a FINAL submission. Please note that if you do not mark your abstract as complete and make a FINAL submission, it will NOT be considered. Take note of any deadlines under the appropriate call for abstracts and be sure to complete the process on or before that date.
- Do not CREATE your abstract in the submission system, but rather create your abstract in a separate word document and COPY and PASTE into the abstract submission system. In this way, you will not have lost your abstract in the event of disconnection from the Internet, etc. Be sure to check for errors when pasting. Certain special characters may be changed by the browser.
- Make sure that the person submitting the abstract is the lead author of the submission. (The submitter's information will appear on the abstract as being the lead author.)
- If you are currently a member of the NLA, we will prefill your address information for you in the online submission form based on your current lipid.org account information profile. Note that changes made here will apply to your abstract only and WILL NOT BE APPLIED to your NLA member record or lipid.org account.
- The lead author must register for the 2012 NLA Annual Scientific Sessions to ensure their abstract(s) are included in the abstract publication and website. Deadline for author registration is May 11, 2012. Lead authors must be registrants at the NLA Annual Scientific Sessions. If accepted, lead authors who are active members of the NLA will receive a $100 credit in the form of LipidBucksTM to apply toward the registration fee, or another NLA-sponsored activity. (NLA Staff will contact you with a meeting registration form when your abstract is accepted). Authors who are not members of the NLA must pay the non-member registration fee.
- It is the responsibility of the presenting author to ensure that the abstract is submitted correctly.
- Abstracts will be reviewed by the appointed NLA Abstract Review Committee.
- Faxed or mailed hard-copy abstracts or abstracts sent on a CD/disc WILL NOT be accepted. If you are unable to submit via the website, please contact the NLA Annual Meeting Staff:
Phone: 904-998-0854
Fax: 904-998-0855
Email: posters@lipid.org
Disclaimer
The NLA will not be responsible for abstract submissions not received via the website or for submission errors caused by internet service outages, hardware or software delays, power outages or unforeseen events.

Abstract Guidelines
Content Guidelines
Abstracts for poster entries submitted for competition can only be accepted electronically and must adhere to the following guidelines:
- Abstracts are limited to 400 words.
- Abstracts must be divided into sections: Title, Synopsis, Objectives/Purpose, Methods, Results, and Conclusion that states the importance and potential implications of the observations.
- Abstracts must be proofread carefully to avoid errors before submission.
- Abstracts must contain generic drug names only.
- Abstracts must be submitted in clear English with accurate grammar and spelling of a quality suitable for publication.
- Lead and secondary authors must disclose all financial relationships.
- Any funding support for the research must be disclosed.
- Encore research is eligible for submission but the original date and location of presentation of the research must be disclosed in the application.
Checklist
The purpose of the abstract is to define the precise subject of the presentation to an audience. Below you will find a checklist for abstract preparation. All abstracts are considered equally for selection, and the quality of the abstract is the single most important factor in the Committee's decision.
You will be asked for the following:
- Title
- Background/Synopsis - A concise description of your subject matter and prior work in this area
- Objective/Purpose - The question your material answers or the hypothesis that it tests
- Methods - The experimental design or technique employed
- Results - Outcomes & measurements, with statistical significance, if appropriate
- Conclusion - Conclusions, clinical pertinence, and value or for Workshops and Presentations, the prevailing point of view
- Proofread - Make sure to proofread your abstract. Misspellings and typographical errors reflect badly on your scientific work. Prepare to substitute plain text for special characters as these characters may not be rendered reliably (e.g., plus or minus for ±, alpha for α etc.).
- Authors - For each author you must provide First and Last Name, City and State as well as preliminary financial disclosure information. If you would like to be considered for oral presentation, the Primary Author should also upload a brief paragraph describing their qualifications in the chosen subject area and/or a CV.
- Supplemental Materials for Upload (Optional) - Images that support your work, documents, power point presentations. These uploaded items need not be in their final quality or form.

Abstract Submission Topics
To ensure your abstract receives proper consideration, the abstract must relate to an appropriate topic in the field of clinical lipidology and cardiovascular disease prevention. Abstract authors will be required to indicate which topic BEST matches the content of their abstract. Topics for the 2012 NLA Annual Scientific Sessions are:
- Clinical Applications of Biomarkers, Lipoprotein Testing
- Diabetes, Insulin Resistance and Dyslipidemia
- Enhancing Adherence, Compliance to Therapies
- Epidemiology of Cardiovascular Disease
- Genetics, Gene Therapy and Atherosclerosis
- HDL Modification, Novel HDL Raising Therapies
- Hypertriglyceridemia
- Imaging in Atherosclerosis
- Lipid Management Best Practices (clinic operations, lipid team approaches, outcomes research)
- Lipid Management in Special Populations
- Management of Statin Intolerance
- Nutrition, Nutrigenomics, Nutraceuticals and Exercise Therapies
- Omega-3 fatty acids
- Pathophysiology of Atherosclerosis
- Pharmacological Control of Lipids and Lipoproteins
- Visceral obesity, Metabolic Syndrome and Atherosclerosis
If you do not see an appropriate topic listed above that best relates to your abstract, please contact the NLA office at mailto:posters@lipid.org or call 904-998-0854.

Acceptance and Presentation Process
Abstract grading is blinded and abstracts are pre-screened and selected by NLA judges on the basis of quality and merit. You will be notified by April 16, 2012 if your poster is accepted. All lead poster authors are required to register for and attend the NLA 2012 Annual Scientific Sessions in Scottsdale, AZ, May 31—June 3, 2012, to field questions from NLA judges and attendees.*
*Lead authors who are active members of the NLA will receive $100 in LipidBucksTM credits that may be used to discount registration for the NLA 2012 Annual Scientific Sessions. Expenses related to airfare, lodging, social events/guest fees are the responsibility of the presenter. Special program available for trainees, fellows and young investigators—see Young Investigator Award.
Poster guidelines will be provided to lead authors in mid-April.
Questions? Contact the NLA office at posters@lipid.org or call 904-998-0854.
You must be logged into the NLA Website in order to submit an abstract; however you are not currently logged into the site. Depending on the circumstances, you have one of three options:
- NLA Members who have already setup an account, please login.
- NLA Members who have not setup an account can obtain one by writing the webmaster.
- A guest account can be created for non-members. You may request one by writing the webmaster
|